Nanomedicine and molecular imaging.
Our research integrates molecular imaging into nanomedicine development, both for evaluating in vivo behavior and non-invasively monitoring treatment and efficacy. We exploit the natural ability of our nanoplatforms to interact with myeloid immune cells to selectively deliver inflammation pro-resolving drugs and promote atherosclerosis regression. You will be involved in the generation of a library of pro-resolving nanoformulations as well as in their in vitro characterization and in vivo evaluation in a mouse model of atherosclerosis.
Carlos Pérez Medina.
Correo electrónico: cperez@cnic.es.
Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC).
Número de plazas ofertadas: 2.
Facultad de Medicina. Universidad Autónoma de Madrid. Calle del Arzobispo Morcillo 4. 28029 Madrid. Tel.: +34 914 975 486. Correo electrónico: informacion.medicina@uam.es
